Truces Call By Bulls and Bears: Halliburton Company (NYSE:HAL), EnteroMedics (NASDAQ:ETRM)

Several matter pinch shares of Halliburton Company (NYSE:HAL) [Trend Analysis], as shares moving down -0.42% to $54.84 with a share volume of 3.16 Million. Halliburton Co. (HAL) declared on Friday that it settled a 14-year-old class action lawsuit that had gone to the U.S. Supreme Court. Halliburton said it will contribute $54 million to a $100 million settlement fund in its lawsuit with the Erica P. John Fund, with the company’s insurer contributing the rest. The legal fight was considered a test of the right of investors to file a class-action lawsuit based on public misrepresentations. The stock is going forward its 52-week low with 101.86% and moving down from its 52-week high price with -2.21%. To have technical analysis views, liquidity ratio of a company was calculated 3.20 as evaluated with its debt to equity ratio of 1.27. The float short ratio was 2.32%, as compared to sentiment indicator; Short Ratio was 2.27.

Shares of EnteroMedics Inc. (NASDAQ:ETRM) [Trend Analysis] runs in leading trade, it plunging -7.52% to traded at $0.05. The firm has price volatility of 14.87% for a week and 22.68% for a month. Its beta stands at 2.22 times. EnteroMedics Inc. (ETRM) declared that EnteroMedics Board of Directors has declared a 1-for-70 reverse stock split of the Company’s common stock, which will be effective for trading purposes upon the commencement of trading on December 28, 2016. As of that date, each 70 shares of issued and outstanding common stock and equivalents will be converted into 1 share of common stock.

Any fractional shares of common stock resulting from the reverse stock split will be rounded up to the nearest whole share and any fractional shares of common stock issuable pursuant to stock options or warrants will be rounded down to the nearest whole share.

The reverse stock split is being effected as part of the Company’s plan to regain compliance with the $1.00 minimum bid price continued listing requirement of the NASDAQ Capital Market. EnteroMedics stockholders will receive instructions from its transfer agent, Wells Fargo Bank National Association, as to procedures for exchanging existing stock certificates for new certificates or book-entry shares. Narrow down four to firm performance, its weekly performance was -20.04% and monthly performance was -35.00%. The stock price of ETRM is moving down from its 20 days moving average with -21.75% and isolated negatively from 50 days moving average with -36.14%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *